phenacyl bromide has been researched along with masoprocol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Denda, A; Endoh, T; Horiguchi, K; Kobayashi, E; Konishi, Y; Nakae, D; Noguchi, O; Ogasawara, H; Sugimura, M; Tamura, K; Tang, Q; Tsujiuchi, T | 1 |
| Cholidis, S; Hartmann, C; Rieck, PW | 1 |
2 other study(ies) available for phenacyl bromide and masoprocol
| Article | Year |
|---|---|
Inhibition by acetylsalicylic acid, a cyclo-oxygenase inhibitor, and p-bromophenacylbromide, a phospholipase A2 inhibitor, of both cirrhosis and enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats.
Topics: Acetophenones; Animals; Aspirin; Choline; Choline Deficiency; Cyclooxygenase Inhibitors; Fatty Liver; gamma-Glutamyltransferase; Glutathione Transferase; Lipoxygenase Inhibitors; Liver; Liver Cirrhosis, Experimental; Liver Neoplasms, Experimental; Male; Masoprocol; Methionine; Oxidative Stress; Phospholipases A; Phospholipases A2; Precancerous Conditions; Quercetin; Rats; Rats, Inbred F344; Time Factors | 1996 |
Intracellular signaling pathway of FGF-2-modulated corneal endothelial cell migration during wound healing in vitro.
Topics: Acetophenones; Analysis of Variance; Animals; Bromodeoxyuridine; Cattle; Cell Communication; Cell Movement; Cells, Cultured; Chromones; Culture Media, Serum-Free; Endothelium, Corneal; Fibroblast Growth Factor 2; Indomethacin; Masoprocol; Morpholines; Normal Distribution; Pertussis Toxin; Piperazine; Piperazines; Protein Kinase C; Tetradecanoylphorbol Acetate; Virulence Factors, Bordetella; Wound Healing | 2001 |